Foto del docente

Andrea Ardizzoni

Professore ordinario

Dipartimento di Scienze Mediche e Chirurgiche

Settore scientifico disciplinare: MED/06 ONCOLOGIA MEDICA

Direttore Scuola di Specializzazione Oncologia Medica (DI 68/2015)

Pubblicazioni

Garon, Edward B.; Lu, Shun; Goto, Yasushi; De Marchi, Pedro; Paz-Ares, Luis; Spigel, David R.; Thomas, Michael; Yang, James Chih-Hsin; Ardizzoni, Andrea; Barlesi, Fabrice; Orlov, Sergey; Yoshioka, Hiroshige; Mountzios, Giannis; Khanna, Sadhvi; Bossen, Claudia; Carbini, Mariana; Turri, Sabine; Myers, Andrea; Cho, Byoung Chul, Canakinumab as Adjuvant Therapy in Patients With Completely Resected Non–Small-Cell Lung Cancer: Results From the CANOPY-A Double-Blind, Randomized Clinical Trial, «JOURNAL OF CLINICAL ONCOLOGY», 2024, 42, pp. 180 - 191 [articolo]

Di Federico A.; De Giglio A.; Sperandi F.; Melotti B.; Ardizzoni A.; Gelsomino F., Effective retreatment with osimertinib in CNS-relapsed epidermal growth factor receptor-mutant non-small cell lung cancer patient following resection and adjuvant osimertinib, «ANTI-CANCER DRUGS», 2024, 35, pp. 86 - 88 [articolo]

Guido, Alessandra; Cuicchi, Dajana; Castellucci, Paolo; Cellini, Francesco; Di Fabio, Francesca; Llimpe, Fabiola Lorena Rojas; Strigari, Lidia; Buwenge, Milly; Cilla, Savino; Deodato, Francesco; Macchia, Gabriella; Galietta, Erika; Golfieri, Rita; Ardizzoni, Andrea; Zagari, Rocco Maurizio; Fanti, Stefano; Poggioli, Gilberto; Fuccio, Lorenzo; Morganti, Alessio G, Adaptive Individualized high-dose preoperAtive (AIDA) chemoradiation in high-risk rectal cancer: a phase II trial, «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2023, 50, pp. 572 - 580 [articolo]Open Access

Sisi, Monia; Vitale, Giovanni; Fusaroli, Michele; Riefolo, Mattia; Giunchi, Valentina; D’Errico, Antonietta; Ardizzoni, Andrea; Raschi, Emanuel; Gelsomino, Francesco, Capmatinib-Induced Liver Injury as Emerging Toxicity of MET Inhibitors in Patients With NSCLC Pretreated With Immune Checkpoint Inhibitors, «JTO CLINICAL AND RESEARCH REPORTS», 2023, 4, Article number: 100563, pp. 1 - 8 [articolo]

Zhou, Caicun; Solomon, Benjamin; Loong, Herbert H.; Park, Keunchil; Pérol, Maurice; Arriola, Edurne; Novello, Silvia; Han, Baohui; Zhou, Jianying; Ardizzoni, Andrea; Mak, M. Perez; Santini, Fernando C.; Elamin, Yasir Y.; Drilon, Alexander; Wolf, Jürgen; Payakachat, Nalin; Uh, Minji K.; Rajakumar, Deborah; Han, Hongmei; Puri, Tarun; Soldatenkova, Victoria; Lin, A. Bence; Lin, Boris K.; Goto, Koichi, First-Line Selpercatinib or Chemotherapy and Pembrolizumab in RET Fusion–Positive NSCLC, «THE NEW ENGLAND JOURNAL OF MEDICINE», 2023, 389, pp. 1839 - 1850 [articolo]

Rossi, Simone; Cani, Ilaria; Raschi, Emanuel; Comito, Francesca; Rinaldi, Rita; Ardizzoni, Andrea; Guarino, Maria; Gelsomino, Francesco, Neurological Manifestations as a Harbinger of Myocarditis in Patients Treated With Immune Checkpoint Inhibitors, «JOURNAL OF CLINICAL ONCOLOGY», 2023, 41, pp. 1151 - 1153 [replica/breve intervento]

Moliner, Laura; Zhang, Bingnan; Lamberti, Giuseppe; Ardizzoni, Andrea; Byers, Lauren A.; Califano, Raffaele, Novel therapeutic strategies for recurrent SCLC, «CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY», 2023, 186, Article number: 104017, pp. 1 - 9 [articolo]

Rossi S.; Gelsomino F.; Rinaldi R.; Muccioli L.; Comito F.; Di Federico A.; De Giglio A.; Lamberti G.; Andrini E.; Mollica V.; D'Angelo R.; Baccari F.; Zenesini C.; Madia P.; Raschi E.; Cortelli P.; Ardizzoni A.; Guarino M., Peripheral nervous system adverse events associated with immune checkpoint inhibitors, «JOURNAL OF NEUROLOGY», 2023, 270, pp. 2975 - 2986 [articolo]Open Access

Di Federico, Alessandro; De Giglio, Andrea; Gelsomino, Francesco; Sperandi, Francesca; Melotti, Barbara; Ardizzoni, Andrea, Predictors of Survival to Immunotherapy and Chemoimmunotherapy in Non-Small Cell Lung Cancer: A Meta-Analysis, «JOURNAL OF THE NATIONAL CANCER INSTITUTE», 2023, 115, pp. 29 - 42 [articolo]

Andrini, Elisa; Lamberti, Giuseppe; Mazzoni, Francesca; Riccardi, Ferdinando; Bonetti, Andrea; Follador, Alessandro; Artioli, Fabrizio; Genova, Carlo; Barbieri, Fausto; Frassoldati, Antonio; Brighenti, Matteo; Colantonio, Ida; Pasello, Giulia; Ficorella, Corrado; Cinieri, Saverio; Tiseo, Marcello; Gelsomino, Francesco; Tognetto, Michele; Rihawi, Karim; Ardizzoni, Andrea, A phase II, open-label, single arm, trial of carboplatin plus etoposide with bevacizumab and atezolizumab in patients with extended-stage small-cell lung cancer (CeLEBrATE study): background, design and rationale, «FUTURE ONCOLOGY», 2022, 1027, pp. 1 - 5 [articolo]

Ruzzi, Francesca; Angelicola, Stefania; Landuzzi, Lorena; Nironi, Elena; Semprini, Maria Sofia; Scalambra, Laura; Altimari, Annalisa; Gruppioni, Elisa; Fiorentino, Michelangelo; Giunchi, Francesca; Ferracin, Manuela; Astolfi, Annalisa; Indio, Valentina; Ardizzoni, Andrea; Gelsomino, Francesco; Nanni, Patrizia; Lollini, Pier-Luigi; Palladini, Arianna, ADK-VR2, a cell line derived from a treatment-naïve patient with SDC4-ROS1 fusion-positive primarily crizotinib-resistant NSCLC: a novel preclinical model for new drug development of ROS1- rearranged NSCLC, «TRANSLATIONAL LUNG CANCER RESEARCH», 2022, 11, pp. 2216 - 2229 [articolo]Open Access

Raschi E.; Fusaroli M.; Giunchi V.; Repaci A.; Pelusi C.; Mollica V.; Massari F.; Ardizzoni A.; Poluzzi E.; Pagotto U.; Di Dalmazi G., Adrenal Insufficiency with Anticancer Tyrosine Kinase Inhibitors Targeting Vascular Endothelial Growth Factor Receptor: Analysis of the FDA Adverse Event Reporting System, «CANCERS», 2022, 14, Article number: 4610, pp. 1 - 13 [articolo]Open Access

Noronha, Ashish; Belugali Nataraj, Nishanth; Lee, Joo Sang; Zhitomirsky, Benny; Oren, Yaara; Oster, Sara; Lindzen, Moshit; Mukherjee, Saptaparna; Will, Rainer; Ghosh, Soma; Simoni-Nieves, Arturo; Verma, Aakanksha; Chatterjee, Rishita; Borgoni, Simone; Robinson, Welles; Sinha, Sanju; Brandis, Alexander; Kerr, D Lucas; Wu, Wei; Sekar, Arunachalam; Giri, Suvendu; Chung, Youngmin; Drago-Garcia, Diana; Danysh, Brian P; Lauriola, Mattia; Fiorentino, Michelangelo; Ardizzoni, Andrea; Oren, Moshe; Blakely, Collin M; Ezike, Jideofor; Wiemann, Stefan; Parida, Laxmi; Bivona, Trever G; Aqeilan, Rami I; Brugge, Joan S; Regev, Aviv; Getz, Gad; Ruppin, Eytan; Yarden, Yosef, AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer, «CANCER DISCOVERY», 2022, 12, pp. 2666 - 2683 [articolo]Open Access

Comito, Francesca; Pagani, Rachele; Grilli, Giada; Sperandi, Francesca; Ardizzoni, Andrea; Melotti, Barbara, Emerging Novel Therapeutic Approaches for Treatment of Advanced Cutaneous Melanoma, «CANCERS», 2022, 14, pp. 1 - 24 [articolo]Open Access

Ardizzoni, Andrea; Azevedo, Sergio; Rubio-Viqueira, Belen; Rodriguez-Abreu, Delvys; Alatorre-Alexander, Jorge; Smit, Hans J M; Yu, Jinming; Syrigos, Konstantinos; Höglander, Elen; Kaul, Monika; Tolson, Jonathan; Hu, Youyou; Vollan, Hans Kristian; Newsom-Davis, Thomas, Final results from TAIL: updated long-term efficacy of atezolizumab in a diverse population of patients with previously treated advanced non-small cell lung cancer, «JOURNAL FOR IMMUNOTHERAPY OF CANCER», 2022, 10, Article number: e005581, pp. 1 - 5 [articolo]Open Access